MARKET WIRE NEWS

BeOne Medicines AG (ONC) Q4 2025 Earnings Call Transcript

Source: SeekingAlpha

2026-02-26 16:07:50 ET

BeOne Medicines AG (ONC) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST

Company Participants

Daniel Maller - Vice President of Investor Relations
John Oyler - Co-Founder, Executive Chairman & CEO
Aaron Rosenberg - Chief Financial Officer
Wang Lai - President and Global Head of Research & Development
Matt Shaulis
Xiaobin Wu
Amit Agarwal
Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors
...

Read the full article on Seeking Alpha

For further details see:

BeOne Medicines AG (ONC) Q4 2025 Earnings Call Transcript
BeiGene

NASDAQ: BEIGF

BEIGF Trading

0.0% G/L:

$23.75 Last:

100 Volume:

$23.75 Open:

mwn-ir Ad 300

BEIGF Latest News

BEIGF Stock Data

$38,603,023,416
747,457,849
N/A
299
N/A
Biotechnology & Life Sciences
Healthcare
CH
Basel

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App